Clinical features and risk factors of immune-mediated liver injury in non-small cell lung cancer patients treated with immune checkpoint inhibitors

Clinical features and risk factors of immune-mediated liver injury in non-small cell lung cancer patients treated with immune checkpoint inhibitors

PurposeThis study investigated the clinical features, risk factors, and recurrence of immune-mediated liver injury (IMLI) in non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs).MethodsA retrospective cohort of 274 NSCLC patients receiving ICIs was analyzed. B...

Full description

Saved in:
Bibliographic Details
Main Authors: Ling Yang, Chao Zhuo, Chonghuan Li, Yujing Liu, Xinyi Liu, Yibin Huang, Bingbing Wu, Jiawei Su
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Oncology
Subjects:
immune checkpoint inhibitors
immune-mediated liver injury
immune-related adverse events
clinical features
inflammatory biomarkers
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1575376/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items